Albert Isidro-Llobet
Molecular Biology · 2009–2010
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 9 citations into it
- Organic Chemistry — 5 citations into it
Whom Albert Isidro-Llobet trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Albert Isidro-Llobet's perspective
Ordered by how strongly the researchers Albert Isidro-Llobet trusts endorse each paper. Same corpus, a different order for every researcher.
- Escape from flatland: increasing saturation as an approach to improving clinical success.
- Drugs for bad bugs: confronting the challenges of antibacterial discovery (Nature reviews. Drug discovery)
- A planning strategy for diversity-oriented synthesis. (Angewandte Chemie)
- Structural diversity of organic chemistry. A scaffold analysis of the CAS Registry.
- Natural products as sources of new drugs over the last 25 years. (Journal of Natural Products)
- Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery (Journal of chemical information and computer sciences)
- A new multipoint method for genome-wide association studies by imputation of genotypes (Nature Genetics)
- Active genes are tri-methylated at K4 of histone H3 (Nature)
- Bacterial flagellin is a dominant antigen in Crohn disease. (Journal of Clinical Investigation)
- A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 (Nature Genetics)
Their papers
- Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. (2010) — 700 citations
- Amino acid-protecting groups. (2009) — 663 citations